Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
SKOUT now features a ~40%* increase in sensitivity for clinically significant polyps, nearly doubled detection speed, and enhanced training for sessile polyp recognition. Unio stands out as the first ...